MedTrace Logo

Application of Wearable Technology in High-risk Surgical Patients in the Perioperative Period

NCT05642988 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-12-22

No results posted yet for this study

Summary

Unrecognised changes in patients' vital signs after surgery can result in preventable complications. Current standard practice includes routine monitoring of patient vital signs up until hospital discharge.

Upon discharge from hospital, all forms of routine vital sign monitoring ceases. The availability and use of wearable technology in healthcare is increasing rapidly. The role of wearable technology in the remote monitoring of patients at high-risk of post-operative complications and hospital readmission after discharge from hospital is unclear.

This pilot study is aimed to assess the feasibility of using wearable technology in patients recovering from major intracavity surgery after hospital discharge in the Irish healthcare setting.

Conditions

  • Adult ALL
  • Surgery
  • Anesthesia
  • Postoperative Complications

Interventions

DEVICE

LifeSignals 1AX Biosensor

Biosensor worn by patients for 30-days after intra-abdominal or pelvic surgery on discharge from hospital

Sponsors & Collaborators

  • Health Service Executive, Ireland

    collaborator OTHER

  • Mater Misericordiae University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-12-01
Completion
2023-12-01
FDA Device
Yes

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05642988 on ClinicalTrials.gov